Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D: lack of efficiency due to absence of Fc gammaR-inhibiting activity?

Transfusion. 1997 Apr;37(4):444-5; author reply 445-6. doi: 10.1046/j.1537-2995.1997.37497265348.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Chronic Disease
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic / therapy*
  • Receptors, IgG / antagonists & inhibitors*
  • Rho(D) Immune Globulin / immunology*

Substances

  • Antibodies, Monoclonal
  • Receptors, IgG
  • Rho(D) Immune Globulin